Modulation of Rho GTPase activity in endothelial cells by selective proteinase-activated receptor (PAR) agonists.
about
Small G proteins in the cardiovascular system: physiological and pathological aspectsNeurogenic components of trypsin- and thrombin-induced inflammation in rat skin, in vivo.Local protease signaling contributes to neural tube closure in the mouse embryoTissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration.RhoA GTPase switch controls Cx43-hemichannel activity through the contractile systemMalaria biology and disease pathogenesis: insights for new treatments.'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage.Cytoskeletal mechanisms regulating vascular endothelial barrier function in response to acute lung injuryClinical relevance of proteinase activated receptors (pars) in the gutProtein kinase C-related kinase and ROCK are required for thrombin-induced endothelial cell permeability downstream from Galpha12/13 and Galpha11/q.Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more.Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice.EPAC proteins transduce diverse cellular actions of cAMP.Epidermal growth factor receptor transactivation is required for proteinase-activated receptor-2-induced COX-2 expression in intestinal epithelial cells.Protease-activated receptors-1 and -2 can mediate endothelial barrier protection: role in factor Xa signaling.Tissue factor enhances protease-activated receptor-2-mediated factor VIIa cell proliferative properties.Integrin alphavbeta5 regulates lung vascular permeability and pulmonary endothelial barrier function.Role of CL-100, a dual specificity phosphatase, in thrombin-induced endothelial cell activation.Protease-activated receptor 2-dependent phosphorylation of the tissue factor cytoplasmic domain.The Potential of a Novel Class of EPAC-Selective Agonists to Combat Cardiovascular Inflammation.
P2860
Q27010607-2B0041B0-D320-4C64-8001-21C4B0C30D68Q33229884-A175BB9E-8BB6-4635-8F31-0E87D0941B15Q33657566-6444AA10-9632-46A9-BE0A-359C88CDC7A7Q33723243-F4AEDA86-41C7-41EA-A1AC-F533529D22ECQ34364473-83B5EFB6-8A2A-4F95-AFA3-8E87C7CA97F9Q34579700-4B16DF16-6D01-41F5-99F6-16DF1E514521Q34686193-044A8FF2-C9C3-45D3-8715-FE8A7CB856BDQ35212825-95E03FED-624C-428F-8AC5-D56F46EBD9F4Q36124432-DBF98FD0-20B7-46F4-865F-50DD60C00EB4Q36949386-B563F3CF-E1F0-4493-99EF-4EEA23DCE1EEQ37024500-4C9AFB27-2501-4CBA-80BB-489E537B8A81Q37241418-F91C8277-634D-402B-AD20-4FBF6B23EF5CQ37390882-4CC39CBD-C863-44BF-BDA5-F1C3DEE49A78Q39361882-35ED924C-B468-4E0D-8166-7215A75B8199Q40339371-A440ECB1-6725-48BE-8212-20622053F460Q40427301-6E6AD8E7-4E02-4696-A8C7-F10FE78CFA45Q41811902-5EBA5A74-62F0-428F-9BE4-6890D5213E7EQ45038622-810730B5-DC14-458D-AB7F-950739E91B81Q46573809-E765B1D9-6AD6-4C28-993C-E521C505AE77Q48172039-C7263445-B872-41F5-BF99-1E4BD7649C3F
P2860
Modulation of Rho GTPase activity in endothelial cells by selective proteinase-activated receptor (PAR) agonists.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Modulation of Rho GTPase activ ...... vated receptor (PAR) agonists.
@en
Modulation of Rho GTPase activ ...... proteinase-activated receptor
@nl
type
label
Modulation of Rho GTPase activ ...... vated receptor (PAR) agonists.
@en
Modulation of Rho GTPase activ ...... proteinase-activated receptor
@nl
prefLabel
Modulation of Rho GTPase activ ...... vated receptor (PAR) agonists.
@en
Modulation of Rho GTPase activ ...... proteinase-activated receptor
@nl
P2093
P2860
P1476
Modulation of Rho GTPase activ ...... vated receptor (PAR) agonists.
@en
P2093
Van Obberghen-Schilling E
Vouret-Craviari V
P2860
P304
P356
10.1046/J.1538-7836.2003.00238.X
P577
2003-05-01T00:00:00Z